<DOC>
	<DOCNO>NCT00815867</DOCNO>
	<brief_summary>Main objective : Assessing effect epoetin beta Hb rate glomerular filtration rate estimate 30 day kidney transplant .</brief_summary>
	<brief_title>Effect Epoetin Beta Renal Function Within 30 Days Following Kidney Transplant</brief_title>
	<detailed_description>French study , prospective , multicenter , open , randomize two parallel group : Group A : NeoRecormon ® 30000 UI : 4 injection Group B : control group without administration medical product Period recruitment : 18 month Duration participation patient : 90 day Total duration test : 21 month . Main objective : Assessing effect epoetin beta glomerular filtration rate estimate 30 day kidney transplant . Secondary objective : Comparing 2 group time J0 J90 : - The evolution renal function - The survival patient graft - The time onset incidence acute rejection prove biopsy - The correction anemia - The need transfusion - The need EPO - Quality Life - The safety processing</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Males anf Females age 18 75 Patients give write consent Patient determine participate test respect requirement Patient cover social insurance Patient kidney transplant ( cadaveric donor ) Patient benefit 1st 2nd kidney transplant Patient formerly treat peritoneal dialysis hemodialysis Patient receiving graft risk delay graft function ( score &gt; 7 combining age donor , ischemia time , receiver ethnicity cause death ) Patient receive treatment basiliximab , mycophenolate mofetil , tacrolimus corticosteroid Patient Pregnant nursing Patient disability ensure good understanding study imperative , patient dependency ( alcohol , drug ) Patient receive dos epoetin beta alpha &gt; 30,000 IU / week darbepoetin &gt; 150 microg / week transplant Patient participate clinical trial last month currently include another test Patient safeguard justice , guardianship trusteeship Patient receive third transplant hyper immune positive historic crossmatch Patient receive preemptive transplant graft live donor graft 3 artery MultiOrgan Transplantation Patient heart failure stage &gt; III Patients unstable ischemic heart disease , major coronary event le 6 month , stroke TIA &lt; 6 month symptomatic arteritis lower limbs stage ≥ 3 Patients active viral infection : hepatitis B , C ( PCR + ) HIV Patient history anemia erythroblastopenia Patient receive anticoagulant treatment ( AVK ) renal transplantation continue transplant Patient preoperative rate Hb &gt; 14 g / dL ( ultrafiltration ) A patient know hypersensitivity active substance excipients , benzoic acid Patients poorly control hypertension week transplantation ( Diastolic Blood Pressure ≥ 110 mm Hg 3 antihypertensive drug )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>kidney failure</keyword>
	<keyword>kidney transplant</keyword>
	<keyword>graft function</keyword>
	<keyword>haemoglobin</keyword>
	<keyword>epoetin</keyword>
</DOC>